TCA
DGX icon

Teewinot Capital Advisers’s Quest Diagnostics DGX Stock Holding History

Teewinot Capital Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.61M Buy
28,625
+10,506
+58% +$2.04M 0.45% 23
2025
Q4 		$3.14M Hold
18,119
– – 0.23% 26
2025
Q3 		$3.45M Buy
18,119
+9,445
+109% +$1.68M 0.27% 26
2025
Q2 		$1.56M Sell
8,674
-3,947
-31% -$686K 0.13% 29
2025
Q1 		$2.14M Buy
+12,621
New +$2.07M 0.22% 28

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Teewinot Capital Advisers's DGX Position: Q1 2026 in Review

Teewinot Capital Advisers increased its Quest Diagnostics (DGX) stake by 58% in Q1 2026, buying an estimated $2.04M and bringing the position to 28,625 shares worth $5.61M. The position accounts for 0.45% of the portfolio, ranked #23.

Teewinot Capital Advisers first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Teewinot Capital Advisers held 28,625 shares of Quest Diagnostics worth $5.61M as of Q1 2026.
  • Teewinot Capital Advisers bought 10,506 Quest Diagnostics shares in Q1 2026, an estimated $2.04M.
  • Quest Diagnostics made up 0.45% of Teewinot Capital Advisers's portfolio in Q1 2026, its #23 holding.
  • Teewinot Capital Advisers first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Teewinot Capital Advisers's 13F filing for Q1 2026, filed 15 May 2026.